Risperidone versus haloperidol in psychotic patients with disturbing neuroleptic-induced extrapyramidal symptoms: a double-blind, multi-center trial.

Heck, A H; Haffmans, P M; de Groot, I W; Hoencamp, E

Heck, A H; Haffmans, P M; de Groot, I W; Hoencamp, E.

Affiliation

Heck AH; Psychiatric Center Zon en Schild, Amersfoort, Netherlands.

Schizophr Res ; 46(2-3): 97-105, 2000 Dec 15.

Article in En | MEDLINE | ID: mdl-11120421

Subject(s)

Antipsychotic Agents/therapeutic use; Basal Ganglia Diseases/chemically induced; Haloperidol/therapeutic use; Psychotic Disorders/drug therapy; Risperidone/therapeutic use; Antipsychotic Agents/administration & dosage; Antipsychotic Agents/adverse effects; Basal Ganglia Diseases/diagnosis; Brief Psychiatric Rating Scale; Dose-Response Relationship, Drug; Double-Blind Method; Female; Haloperidol/administration & dosage; Haloperidol/adverse effects; Humans; Male; Psychotic Disorders/diagnosis; Risperidone/administration & dosage; Risperidone/adverse effects; Schizophrenia/complications; Severity of Illness Index

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Psychotic Disorders / Antipsychotic Agents / Basal Ganglia Diseases / Risperidone / Haloperidol Type of study: Clinical_trials / Diagnostic_studies Limits: Female / Humans / Male Language: En Journal: Schizophr Res Journal subject: PSIQUIATRIA Year: 2000 Type: Article Affiliation country: Netherlands

Search on Google

XML

PubMed Links